Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1097/RLU.0000000000006210 http://scihub22266oqcxt.onion/10.1097/RLU.0000000000006210 41359353!?!41359353 Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=41359353&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Clin+Nucl+Med 2025 ; ? (?): ? Nephropedia Template TP {{tp|p=41359353|t=2025. Exploratory Analysis of 68Ga Ga-FAP-2286 PET/CT Quantitative Parameters for Predicting Response to 177Lu Lu-FAP-2286 Therapy in Non-small Cell Lung Cancer |pdf=|usr=}}{{41359353}} gab.com Text Exploratory Analysis of 68Ga Ga-FAP-2286 PET/CT Quantitative Parameters for Predicting Response to 177Lu Lu-FAP-2286 Therapy in Non-small Cell Lung Cancer JO: Clin Nucl Med http://www.kidney.de/pget.php?&tw=1&pmid=41359353 #FOAvip BACKGROUND: This exploratory study aimed to assess the prognostic value of quantitative parameters derived from [68Ga]Ga-FAP-2286 PET/CT in predicting treatment response to [177Lu]Lu-FAP-2286 radioligand therapy in patients with non-small cell lung cancer (NSCLC). PATIENTS AND METHODS: Patients with histologically confirmed NSCLC underwent [68Ga]Ga-FAP-2286 PET/CT before and after 2 cycles of [177Lu]Lu-FAP-2286 therapy. Based on clinical outcomes, patients were classified as responders or nonresponders. Quantitative PET/CT parameters-including maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), FAPI-avid tumor volume (FTV), total lesion FAP expression (TLF), and tumor-to-background ratio (TBR)-were evaluated. Progression-free survival (PFS) and overall survival (OS) were compared using the Kaplan-Meier method and log-rank test. RESULTS: In this cohort of 18 NSCLC patients, baseline PET parameters, including FTV, TLF, and TBR, were significant predictors. Interval PET parameters, such as SUVmax, FTV, TLF, and TBR, were significant predictors of treatment response. In addition, DeltaPET parameters DeltaSUVmax, DeltaFTV, and DeltaTLF also correlated with therapeutic outcomes. The responder group had a median progression-free survival (mPFS) of 14.4 months, while the nonresponder group had an mPFS of 7.15 months. The OS for the responder group was not reached, whereas the nonresponder group exhibited an OS of 12 months. CONCLUSIONS: Quantitative parameters derived from [68Ga]Ga-FAP-2286 PET/CT are valuable predictors of [177Lu]Lu-FAP-2286 treatment efficacy in NSCLC patients. Dynamic monitoring of these metrics allows for early identification of treatment responses and supports personalized therapy strategies. Twit Text FOAVip Exploratory Analysis of 68Ga Ga-FAP-2286 PET/CT Quantitative Parameters for Predicting Response to 177Lu Lu-FAP-2286 Therapy in Non-small Cell Lung Cancer ????Clin Nucl Med http://www.kidney.de/pget.php?&tw=1&pmid=41359353 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=41359353 #FOAvip English Wikipedia <ref>{{Cite pmid|41359353}}</ref> Exploratory Analysis of 68Ga Ga-FAP-2286 PET/CT Quantitative Parameters for Predicting Response to 177Lu Lu-FAP-2286 Therapy in Non-small Cell Lung Cancer #MMPMID41359353 Fan M; Guo X; Liu G; Tian C; Zhao J; Chen Y Clin Nucl Med 2025[Nov]; ? (?): ? PMID41359353show ga BACKGROUND: This exploratory study aimed to assess the prognostic value of quantitative parameters derived from [68Ga]Ga-FAP-2286 PET/CT in predicting treatment response to [177Lu]Lu-FAP-2286 radioligand therapy in patients with non-small cell lung cancer (NSCLC). PATIENTS AND METHODS: Patients with histologically confirmed NSCLC underwent [68Ga]Ga-FAP-2286 PET/CT before and after 2 cycles of [177Lu]Lu-FAP-2286 therapy. Based on clinical outcomes, patients were classified as responders or nonresponders. Quantitative PET/CT parameters-including maximum standardized uptake value (SUVmax), mean standardized uptake value (SUVmean), FAPI-avid tumor volume (FTV), total lesion FAP expression (TLF), and tumor-to-background ratio (TBR)-were evaluated. Progression-free survival (PFS) and overall survival (OS) were compared using the Kaplan-Meier method and log-rank test. RESULTS: In this cohort of 18 NSCLC patients, baseline PET parameters, including FTV, TLF, and TBR, were significant predictors. Interval PET parameters, such as SUVmax, FTV, TLF, and TBR, were significant predictors of treatment response. In addition, DeltaPET parameters DeltaSUVmax, DeltaFTV, and DeltaTLF also correlated with therapeutic outcomes. The responder group had a median progression-free survival (mPFS) of 14.4 months, while the nonresponder group had an mPFS of 7.15 months. The OS for the responder group was not reached, whereas the nonresponder group exhibited an OS of 12 months. CONCLUSIONS: Quantitative parameters derived from [68Ga]Ga-FAP-2286 PET/CT are valuable predictors of [177Lu]Lu-FAP-2286 treatment efficacy in NSCLC patients. Dynamic monitoring of these metrics allows for early identification of treatment responses and supports personalized therapy strategies. ?Exploratory Analysis of 68Ga Ga-FAP-2286 PET/CT Quantitative Paramete(epmc).pdf DeepDyve Pubget Overpricing